Drug Interactions With Risk of QT-prolongation in a General Hospital In this epidemiological point prevalence study, medication profiles of patients with haloperidol treatment will be checked for drug interactions with risk of QT-prolongation. Additional cl...

• Country Belgium
• organs None
• Specialty None

QT-prolongation in Psychiatric Hospitals Observational study in 6 psychiatric hospitals in Flanders. Patients are included when a QT-prolonging drug is added to a medication profile that already contains a potential QT-prolonging...

• Country None
• organs None
• Specialty None

Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital A prospective, observational study in a university hospital (UZ Leuven). Patients are included when they are treated with a potentional QT-prolonging drug: haloperidol for delirium, antibi...

• Country None
• organs None
• Specialty None